Table 1 Relationship between LINC01468 and clinicopathological parameters in 52 HCC patients.
From: LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2
Variables | All cases | LINC01468 expression | P | |
|---|---|---|---|---|
Low (n = 26) | High (n = 26) | |||
Age (years) | 0.768 | |||
<50 | 35 | 17 | 18 | |
≥50 | 17 | 9 | 8 | |
Gender | 0.150 | |||
Male | 33 | 14 | 19 | |
Female | 19 | 12 | 7 | |
HbA1C | 0.032 | |||
<6.5% | 37 | 22 | 15 | |
≥6.5 | 15 | 4 | 11 | |
Cirrhosis | 0.011 | |||
No | 21 | 15 | 6 | |
Yes | 31 | 11 | 20 | |
Tumor size (cm) | 0.048 | |||
<5 | 21 | 14 | 7 | |
≥5 | 31 | 12 | 19 | |
TNM stage | 0.026 | |||
I–II | 28 | 18 | 10 | |
III–IV | 24 | 8 | 16 | |
Microvascular invasion | 0.012 | |||
Yes | 25 | 8 | 17 | |
No | 27 | 18 | 9 | |
AFP, μg/L | 0.578 | |||
<200 | 24 | 13 | 11 | |
≥200 | 28 | 13 | 15 | |
TG | 0.048 | |||
Yes | 40 | 23 | 17 | |
No | 12 | 3 | 9 | |
TC | 0.039 | |||
Yes | 35 | 21 | 14 | |
No | 17 | 5 | 12 | |
